1999
DOI: 10.1507/endocrj.46.723
|View full text |Cite
|
Sign up to set email alerts
|

Troglitazone Improves Insulin-Stimulated Glucose Utilization Associated with an Increased Muscle Glycogen Content in Obese Zucker Rats.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
12
0

Year Published

2000
2000
2012
2012

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 37 publications
0
12
0
Order By: Relevance
“…There is considerable interest in regulating PDK4 as an approach to the treatment of type 2 diabetes Table 1. (Oshida et al 1999, Sreenan et al 1999, Sugden & Holness 2002. The last transcript in this group is HMG-CoA synthase, which shows enhanced expression.…”
Section: Discussionmentioning
confidence: 95%
“…There is considerable interest in regulating PDK4 as an approach to the treatment of type 2 diabetes Table 1. (Oshida et al 1999, Sreenan et al 1999, Sugden & Holness 2002. The last transcript in this group is HMG-CoA synthase, which shows enhanced expression.…”
Section: Discussionmentioning
confidence: 95%
“…The β-subunit shows 3-oxoacyl-CoA thiolase activity, and the α-subunit provides enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase activity. Concerning dietary regulation of this gene, Oshida et al [38] reported that HADHB activity in muscle was higher in rats fed a high sucrose diet. According to them, the high sucrose group exhibited a metabolic pattern in muscle that favoured carbohydrate over fat oxidation.…”
Section: Discussionmentioning
confidence: 99%
“…Treatment with the insulin sensitizer troglitazone produces a rise in the metabolic clearance rate of glucose during a euglycemic hyperinsulinemic clamp in obese rats and Zucker diabetic rats. 4,5) Troglitazone increases the muscle glycogen content after the clamp, compared with untreated obese rats. Troglitazone may improve insulin sensitivity associated with improvements in intracellular substrate use and energy stores.…”
Section: Discussionmentioning
confidence: 99%
“…These compounds increase peripheral glucose uptake while decreasing gluconeogenesis of the liver in a wide variety of experimental models of type 2 diabetes and in humans. 4,5) The compounds improve glucose tolerance and insulin sensitivity in both diabetic and glucose-intolerant patients. However, troglitazone, one of this class compounds, can cause liver damage and multiple progenies in humans, and is no longer prescribed.…”
mentioning
confidence: 99%